CEO, Inova Schar Cancer Institute
Jun 06, 2018
Donald (Skip) Trump, MD, FACP
CEO, Inova Schar Cancer Institute

Donald “Skip” Trump, MD, joined the Inova Schar Cancer Institute (ISCI) as its Chief Executive Officer on January 5, 2015. Before coming to Inova, Dr. Trump served as president and CEO of Roswell Park Cancer Institute (RPCI) in Buffalo, NY.  Dr. Trump has held previous appointments with the University of Pittsburgh Cancer Institute and School of Medicine, Duke University Medical Center, University of Wisconsin, and the Johns Hopkins University. 

Dr. Trump is a medical oncologist who specializes in the treatment of patients with genitourinary cancers, especially prostate and bladder cancer. He has received peer reviewed research funding from the National Cancer Institute, the Department of Defense and the American Cancer Society.  His personal research work has involved the development of vitamin D-based approaches to cancer prevention and therapy.  Since his assuming the position of CEO, ISCI in 2015, he has recruited more the 30 cancer clinicians and scientists to develop ISCI program in drug discovery, biomarker development, clinical genomics and clinical cancer trials.  ISCI established the first Molecular Tumor Board in the Spring of 2016.

Dr. Trump earned his medical degree at The Johns Hopkins University School of Medicine in Baltimore, where he also completed his internship, residency and medical oncology fellowship training.  He served as chief resident in internal medicine at The Johns Hopkins Hospital.